Table 1
Baseline and Follow-up Survey of HIV-TB Research Capacity at BJGMC.1
| Respondents ranking strength of HIV-TB researchers at BJGMC n (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specific Research Capacity | Responses Received | Very Strong | Strong | Mediocre | Weak | Very Weak | ||||||
| 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | |
| Basic Research Knowledge | 20 | 30 | 0 (0.0) | 2 (6.7) | 6 (30.0) | 16 (53.3) | 6 (30.0) | 9 (30.0) | 5 (25.0) | 3 (10.0) | 3 (15.0) | 0 (0.0) |
| TB Lab Skills | 21 | 30 | 1 (4.8) | 2 (6.7) | 9 (42.9) | 21 (70.0) | 10 (47.6) | 7 (23.3) | 0 (0.0) | 0 (0.0) | 1 (4.8) | 0 (0.0) |
| TB Clinical Knowledge | 22 | 29 | 2 (9.1) | 4 (13.8) | 13 (59.1) | 23 (79.3) | 7 (31.8) | 2 (6.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| TB Epidemiology Knowledge | 21 | 30 | 0 (0.0) | 3 (10) | 8 (38.1) | 20 (66.7) | 9 (42.9) | 7 (23.3) | 4 (19.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Scientific Output | 22 | 30 | 0 (0.0) | 2 (6.7) | 0 (0.0) | 6 (20.0) | 6 (27.3) | 17 (56.6) | 13 (59.1) | 5 (16.7) | 3 (13.6) | 0 (0.0) |
| Linkage with Government | 17 | 30 | 0 (0.0) | 2 (6.7) | 4 (23.5) | 17 (56.7) | 12 (70.6) | 10 (33.3) | 1 (5.9) | 1 (3.3) | 0 (0.0) | 0 (0.0) |
| Respondents Ranking for the areas requiring the most training n (%) | ||||||||||||
| Specific Research Capacity | Responses Received | Strongest need | Strong need | Moderate Need | Weak Need | Weakest Need | ||||||
| 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | |
| Basic Research Knowledge | 18 | 30 | 7 (38.9) | 1 (3.3) | 8 (44.4) | 13 (43.3) | 1 (5.6) | 10 (33.3) | 2 (11.1) | 5 (16.7) | 0 (0.0) | 1 (3.3) |
| TB Lab Skills | 19 | 28 | 3 (15.8) | 0 (0.0) | 10 (52.6) | 9 (32.1) | 4 (21.1) | 14 (50.0) | 2 (10.5) | 2 (7.1) | 0 (0.0) | 3 (10.7) |
| TB Clinical Knowledge | 19 | 30 | 2 (10.5) | 1 (3.3) | 3 (15.8) | 6 (20.0) | 9 (47.4) | 9 (30.0) | 4 (21.0) | 12 (40) | 1 (5.3) | 2 (6.7) |
| TB Epidemiology Knowledge | 20 | 29 | 4 (20.0) | 2 (6.9) | 4 (20.0) | 8 (27.6) | 9 (45.0) | 8 (27.6) | 3 (15.0) | 7 (24.1) | 0 (0.0) | 4 (13.8) |
| Scientific Output | 20 | 30 | 11 (55.0) | 7 (23.3) | 4 (20.0) | 10 (33.3) | 4 (20.0) | 9 (30.0) | 1 (5.0) | 1 (3.3) | 0 (0.0) | 3 (10.0) |
| Linkage with Government | 16 | 29 | 0 (0.0) | 1 (3.4) | 4 (25.0) | 6 (20.7) | 11 (68.8) | 12 (41.4) | 1 (6.2) | 8 (27.6) | 0 (0.0) | 2 (6.9) |
[i] 1 2014: 61 TB experts sent survey, 22 responses received; 2018: 61 TB experts + 20 Fogarty Scholars sent survey, 30 responses received.
Table 2
Baseline and Follow-up Survey of HIV-TB Research Capacity at BJGMC.1
| Respondents Ranking Position of BJGMC to do TB Research with Regards to the following Parameters, n (%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specific Research Capacity | Responses Received | Very Well Positioned, no Gaps | Well Positioned with Some Institutional Gaps | Somewhat Well Positioned with Institutional Gaps | Not Very Well Positioned with Significant Institutional Gaps | Badly Positioned with Major Institutional Gaps | Not Enough Experience to Say | |||||||
| 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | |
| TB Laboratory Facilities | 20 | 28 | 0 (0.0) | 4 (14.3) | 7 (35.0) | 18 (64.3) | 4 (20.0) | 4 (14.3) | 1 (5.0) | 2 (7.1) | 1 (5.0) | 0 (0.0) | 7 (35.0) | 0 (0.0) |
| Good Clinical Laboratory Practice | 20 | 28 | 1 (5.0) | 4 (14.3) | 6 (30.0) | 16 (57.1) | 4 (20.0) | 5 (17.9) | 3 (15.0) | 3 (10.7) | 0 (0.0) | 0 (0.0) | 6 (30.0) | 0 (0.0) |
| TB Clinical Research System | 20 | 28 | 0 (0.0) | 5 (17.9) | 4 (20.0) | 15 (53.6) | 9 (45.0) | 7 (25.0) | 1 (5.0) | 1 (3.5) | 1 (5.0) | 0 (0.0) | 5 (25.0) | 0 (0.0) |
| TB Epidemiologic Investigations | 20 | 28 | 2 (5.0) | 3 (10.7) | 1 (5.0) | 11 (39.3) | 5 (25.0) | 10 (35.7) | 8 (40.0) | 2 (7.1) | 0 (0.0) | 2 (7.1) | 5 (25.0) | 0 (0.0) |
| Ethical Conduct of Research | 20 | 28 | 2 (10.0) | 8 (28.6) | 5 (25.0) | 15 (53.6) | 6 (30.0) | 4 (14.3) | 0 (0.0) | 0 (0.0) | 1 (5.0) | 0 (0.0) | 6 (30.0) | 1 (3.6) |
| Data Management Systems | 19 | 28 | 0 (0.0) | 4 (14.3) | 5 (26.3) | 7 (25.0) | 0 (0.0) | 8 (28.6) | 7 (36.8) | 4 (14.3) | 1 (5.3) | 3 (10.7) | 6 (31.6) | 2 (7.1) |
| Research Dissemination Systems | 20 | 28 | 0 (0.0) | 3 (10.7) | 1 (5.0) | 4 (14.3) | 4 (20.0) | 12 (42.9) | 7 (35.0) | 6 (21.4) | 2 (10.0) | 2 (7.1) | 6 (30.0) | 1 (3.6) |
[i] 1 2014: 61 TB experts sent survey, 20 responses received; 2018: 61 TB experts + 20 Fogarty Scholars sent survey, 30 responses received.
Table 3
Baseline and Follow-up Survey of BJGMC’s TB Research Linkages to.1
| Respondents Ranking Position of BJGMC to do TB Research with Regards to the following Parameters, n (%) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Responses Received | Excellent | Good | Fair | Poor | Terrible | Not Enough Information to Answer | ||||||||
| 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | 2014 | 2018 | |
| Other BJGMC Researchers | 20 | 28 | 0 (0.0) | 5 (17.9) | 4 (20.0) | 11 (39.3) | 2 (10.0) | 11 (39.3) | 1 (5.0) | 0 (0.0) | 1 (5.0) | 0 (0.0) | 12 (60.0) | 1 (3.6) |
| BJGMC Medical Students | 20 | 28 | 0 (0.0) | 3 (10.7) | 3 (15.0) | 9 (32.1) | 3 (15.0) | 12 (42.9) | 4 (20.0) | 2 (7.1) | 1 (5.0) | 0 (0.0) | 9 (45.0) | 2 (7.1) |
| Government Bodies, including the RNTCP | 20 | 29 | 0 (0.0) | 2 (6.9) | 4 (20.0) | 17 (58.6) | 3 (15.0) | 4 (13.8) | 4 (20.0) | 3 (10.3) | 2 (10.0) | 0 (0.0) | 7 (35.0) | 3 (10.3) |
| Other Indian TB Researchers | 19 | 29 | 0 (0.0) | 1 (3.4) | 4 (21.0) | 12 (41.4) | 3 (15.8) | 8 (27.6) | 4 (21.0) | 5 (17.2) | 2 (10.5) | 0 (0.0) | 6 (31.6) | 3 (10.3) |
| Other Foreign TB Researchers | 20 | 29 | 2 (10.0) | 3 (10.3) | 6 (30.0) | 12 (41.4) | 4 (20.0) | 5 (17.2) | 1 (5.0) | 6 (20.7) | 2 (10.0) | 0 (0.0) | 5 (25.0) | 3 (10.3) |
[i] 1 2014: 61 TB experts sent survey, 20 responses received; 2018: 61 TB experts + 20 Fogarty Scholars sent survey, 29 responses received.